C-MER Medical Holdings (HKSE:03309) Moat Score: 0/10 (As of Aug. 29, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HKSE:03309 C-MER Medical Holdings Ltd HKSE:03309
83 GF Score
Price HK$0.86
GF Value HK$2.77
Valuation Possible Value Trap
! 5 Warning Signs
View Full Analysis

What is C-MER Medical Holdings Moat Score?

C-MER Medical Holdings has the Moat Score of 0, which implies that the company might have No Moat - No discernible moat.

C-MER Medical Holdings has

Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more.

The company's Moat Score is based on these criteria:

1. Market leadership and sustainable market share
2. Network effects and significant customer switching costs
3. Valuable intellectual property and patents
4. Strong brand strength and deep customer loyalty
5. Durable cost advantages (e.g., economies of scale, proprietary technology)
6. Significant regulatory barriers and exclusive licenses
7. Superior distribution network
8. Strong and sustainable pricing power
9. Consistent and impactful innovation and R&D capabilities

Based on the research, GuruFocus believes C-MER Medical Holdings might have No Moat - No discernible moat.

C-MER Medical Holdings  (HKSE:03309) Moat Score Explanation

The Moat Score ranges from 0 to 10, with 10 as the highest. GuruFocus divided Moat Score into following 8 categories:

Moat Score Moat Level
10Wide Moat - Exceptionally dominant and durable wide moat
8 - 9Wide Moat - Clear and robust wide moat
7Wide Moat - Entry-level wide moat, clearly possessing durable advantages
6Narrow Moat - Strong narrow moat, clearly distinguishable but not wide
5Narrow Moat - Solid narrow moat
4Narrow Moat - Discernible but modest moat
1 - 3No Moat - Very weak/transient advantages
0No Moat - No discernible moat

C-MER Medical Holdings Moat Score Related Terms

HKSE:03309
83GF Score
C-MER Medical Holdings Ltd HKSE:03309
Moat Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is C-MER Medical Holdings (HKSE:03309) Overvalued in 2026?

Based on GuruFocus' analysis, C-MER Medical Holdings stock appears to be undervalued. The current stock price of HK$0.86 is trading 69.1% below its estimated GF Value™ of HK$2.77. GuruFocus considers C-MER Medical Holdings to be Possible Value Trap.

Key valuation signals for HKSE:03309:

  • Moat Score: 0
  • GF Value™: HK$2.77 vs. price of HK$0.86 (69.1% below fair value)
  • GF Score™: 83/100 with 5 warning signs

No single metric tells the full story. See the HKSE:03309 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

C-MER Medical Holdings Business Description

Address 1-3 Pedder Street, Room 1535, China Construction Building, Central, Hong Kong, HKG
C-MER Medical Holdings Ltd is a ophthalmic medical chain group in Hong Kong and the Greater Bay Area. With ophthalmology as its core, it has gradually expanded its business scope to different specialist services. The company through its subsidiaries are principally engaged in the provision of ophthalmic, dental and other medical services, sales of vision aid products and sales of medical consumables in Hong Kong and Mainland China. Geographically, the company generates revenue from Mailand China, and Hong Kong, with the majority of revenue generated from Mainland China.
83GF Score

Get the complete analysis for HKSE:03309

Moat Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$0.86
Price
HK$2.77
GF Value